Cheyipai Raises US$110 Million in a Series D Financing Round (Asia)

China-based social networking platform Renren has led a US$110 million Series D financing round for China-based second-hand car trading platform Cheyipai. Venture capital firms Sequoia Capital, Matrix Partners and Morningside Technologies and CITIC Capital, the private equity arm of CITIC Capital Holdings, also participated in the round. The company intends… Read More

The Carlyle Group Receives Approval to Buy Destimoney’s Indian Arm (Asia)

The Competition Commission of India has approved Mauritius-based financial services company Destimoney Enterprises’ proposed sale of its Indian arm to Quality Investment Holdings, an entity controlled by alternative asset manager The Carlyle Group, for a reported US$200 million. Carlyle will acquire a 100 percent stake in Destimoney Enterprises’ Indian arm. Read More

InvAscent’s India Life Sciences Fund II Invests Across Two Medical Device Companies (Asia)

India-focused private equity firm InvAscent has invested INR920 million (approximately US$15 million) across two India-based medical device companies: Comprehensive Prosthetics and Orthotics (CPO), a manufacturer of artificial limbs, and Relisys, a manufacturer of medical devices that treat life-threatening diseases. The transactions were structured through India Life Sciences Fund II. InvAscent… Read More

AIF Capital Exits Famy Care Through a Strategic Sale to Mylan (Asia)

Global pharmaceutical company Mylan has signed a definitive agreement to acquire certain female health care businesses from India-based oral contraceptive pill manufacturer Famy Care for US$750 million, plus additional contingent payments of up to US$50 million, facilitating an exit for Asia-focused private equity firm AIF Capital. AIF Capital originally invested… Read More



(default archive template)